Blandine Laferrere, MD
Enriched profileProfessor of Medicine, Columbia University Irving Medical Center · Columbia University Irving Medical Center
Blandine Laferrere is Professor of Medicine, Columbia University Irving Medical Center at Columbia University Irving Medical Center. OpenAlex indexes 220 publications with 14,398 citations (h-index 52); ClinicalTrials.gov lists 13 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.
Data verified 18 Oct 2026
Overview
Updated 18 Oct 2026
Blandine Laferrere, M.D., is Professor of Medicine, Columbia University Irving Medical Center. The public record shows 220 publications with 14,398 citations (h-index 52), centered on Bariatric Surgery and Outcomes, Diabetes Treatment and Management, Diabetes, Cardiovascular Risks, and Lipoproteins. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 1 companies, 12 NIH-funded awards (1998–2026).
- Most recent indexed publication: 2025 · Nutrients
- Top research focus: Bariatric Surgery and Outcomes
- 13 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 19 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 115.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:
- Effect of Insulin Lowering on Lipogenesis
Sponsor: Columbia University
- Human Models of Selective Insulin Resistance: Pancreatic Clamp
Sponsor: Columbia University
- Lifestyle Patterns and Glycemic Control
Sponsor: Columbia University
Industry payments
Updated 18 Oct 2026
1 company reported payments to CMS in program years 2025–2025. These are public disclosures, not judgments. The latest:
- Azurity Pharmaceuticals, Inc.Program year20252 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
70.5%GLP-1 receptor agonist23.1%Ozempic60%Mounjaro40%Part D<11 patientsBiguanide (metformin)19.4%Metformin Hcl Er75%Metformin Hcl25%Part D<11 patients+ 3 more classes in this area
Hormonal (systemic)
19.8%l-Thyroxine19.8%Levothyroxine Sodium100%Part D≥14 patientsCardiovascular
9.7%Statin9.7%Atorvastatin Calcium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
12 NIH research awards on record, funded 1998–2026 per NIH RePORTER. The latest:
- Impact of a plant-based diet on glucose metabolism and mediation by sleep
Columbia University Health Sciences
FY2026$707,820R01DK143589
Congress activity
Updated 18 Oct 2026
12 congress contributions (2011–2026) across AACE, ADA, ENDO per OpenAlex. The most recent:
- 2171-P: Trajectories of Physical Activity during the Mid- to Late-Life Transition and Cognitive Impairment in Persons with Prediabetes or Type 2 Diabetes
ADA Scientific Sessions
ADA2026Co-authorPoster - 2470-P: Optimizing Diazoxide to Study Hyperinsulinemia and De Novo Lipogenesis in MASLD
ADA Scientific Sessions
ADA2026Co-authorPoster
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Predictive models of post-prandial glucose response in persons with prediabetes and early onset type 2 diabetes: A pilot study.
Diabetes, obesity & metabolism
Article2025 - Metabolite signature of diabetes remission in individuals with obesity undergoing weight loss interventions.
Obesity (Silver Spring, Md.)
Article2024
Most-cited works
by citation count (OpenAlex)- 01Definition and diagnostic criteria of clinical obesityArticle1,758 citations2025
- 02Joint international consensus statement for ending stigma of obesityArticle1,137 citations2020
- 03GhrelinArticle1,030 citations2015
- 04
- 05
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/blandine-laferrere-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗
- PhD in Human Biology
Claude Bernard University, Lyon
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗ - Board Certified
Endocrinology, Diabetes and Metabolism
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗
Editorial & leadership roles
journal and society appointments- Director
Hormone and Metabolite Core Laboratory, Diabetes/Obesity Research Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nynorc.cuimc.columbia.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nynorc.cuimc.columbia.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nynorc.cuimc.columbia.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nynorc.cuimc.columbia.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nynorc.cuimc.columbia.edu ↗
Secondary affiliations
appointments beyond the home institution- Director
Hormone and Metabolite Core Laboratory, Diabetes/Obesity Research Center, Columbia University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗ - Member
Endocrine Society
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗ - Member
Obesity Society
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗ - Member
American Diabetes Association
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Rebecca Hahn, MD
Columbia University Irving Medical Center
Susheel Kodali, MD
Columbia University Irving Medical Center
Ronald Wapner, MD
Columbia University Irving Medical Center
Lawrence Honig, MD
Columbia University Irving Medical Center
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School